VERIGRAFT Is Taking A Fresh Approach To Personalized Tissue Grafting

The Swedish company has developed a proprietary method of personalizing venous grafts, and plans to bring it – alongside some other products – to the market.  

Characterized by edema in the extremities, discomfort and numbness, chronic venous disease (CVD) is an illness that impacts approximately 25m adults in the US.

Mechanically, CVD is expressed as either insufficient or backwards flow of blood in various regions of the body – occurring mostly in the legs. Varicose veins can credit their etiologies...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diabetic Care

More from Device Area